TMO - These Analysts Lower Their Forecasts On Thermo Fisher After Q3 Results | Benzinga
Thermo Fisher Scientific Inc. (NYSE: TMO) reported mixed third-quarter financial results and lowered its FY23 guidance.
Thermo Fisher Scientific posted adjusted earnings of $5.69 per share, versus expectations of $5.61 per share. The company’s sales came in at $10.57 billion, compared to estimates of $10.59 billion.
The company said it now expects 2023 revenue to be $42.7 billion (prior $43.4 billion - $44.0 billion) vs. 43.53 billion ...